References
- Stark J J, Lloyd J W, Schellhammer P R. Estrogen receptor activity in a case of Hodgkin's disease. Ann Intern Med 1981; 95: 186–7
- Grufferman S L, Delzell E. Epidemiology of Hodgkin's disease. Epidemiolog Rev 1984; 6: 76–106
- Danel L, Menouni M, Cohen J H, et al. Distribution of androgen and estrogen receptors among lymphoid kind haemopoietic cell lines. Leukemia Res 1985; 9: 1373–8
- Danel L, Martin P, Escrich E, Tubiana N, Fiere D, Saez Androgen S. estrogen and progestin binding sites in human leukemic cells. Int J Cancer 1981; 27: 733–41
- Danel L, Souweine G, Monier J C, Saez S. Specific estrogen binding sites in human lymphoid cells and thymic cells. J Steroid Biochem 1983; 18: 559–63
- Melo N, Hobday D, Dowsett M, et al. Oestrogen receptor (ER) analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunocytochemical methods. Leukemia Res 1990; 14: 949–52
- Weusten J J, Blankenstein M A, Gmelig-Meyling F H, Schuurman H J, Kater L, Thijssen J H. Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrin 1986; 112: 409–14
- Narasimhan P, Amaral L. Lymphopenic response of patients presenting with chronic lymphocytic leukemia associated with carcinoma of the prostate to diethylstilbestrol. Hematol 1980; 8: 369–75
- Issa J P, Zehnbauer B A, Civin C I, et al. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 1996; 56: 973–77
- Jacobs T W, Prioleau J E, Stillman I E, Schnitt S J. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 1996; 88: 1054–59